Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 4/20 | 0.58 |
| ▸ | MAOA | P21397 | 3/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.51 |
| ▸ | MEN1 | O00255 | 3/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.48 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 3/20 | 0.45 |
| ▸ | PTPRC | P08575 | 1/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.44 |
| ▸ | METAP2 | P50579 | 1/20 | 0.44 |
| ▸ | HTR2C | P28335 | 1/20 | 0.43 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13953716 | 0.92 | KMT2A (0.54) | MAOBMAOAKMT2AMEN1TDP1 | |
| SCHEMBL13229080 | 0.92 | KMT2A (0.54) | MAOBMAOAKMT2AMEN1TDP1 | |
| SCHEMBL19497661 | 0.92 | KMT2A (0.54) | MAOBMAOAKMT2AMEN1TDP1 | |
| SCHEMBL13229147 | 0.89 | MAOB (0.51) | MAOBMAOAKMT2AMEN1TDP1 | |
| SCHEMBL13229093 | 0.89 | MAOB (0.51) | MAOBMAOAKMT2AMEN1TDP1 | |
| SCHEMBL13229108 | 0.89 | MAOB (0.47) | MAOBMAOAKMT2AMEN1TDP1 | |
| SCHEMBL13229144 | 0.89 | KMT2A (0.51) | MAOBMAOAKMT2AMEN1TDP1 | |
| SCHEMBL13229095 | 0.89 | KMT2A (0.51) | MAOBMAOAKMT2AMEN1TDP1 | |
| SCHEMBL13229024 | 0.88 | KMT2A (0.52) | MAOBMAOAKMT2AMEN1TDP1 | |
| SCHEMBL13229135 | 0.87 | MAOB (0.50) | MAOBMAOAKMT2AMEN1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11177450-B2 | Organoelectroluminescent element, and light emission device, display device, and illumination device in which said organoelectroluminescent element is used | UDC IRELAND LIMITED (IE) | 2021-11-16 | — | — | US | disclosed |
| US-20140225085-A1 | Organoelectroluminescent Element, and Light Emission Device, Display Device, and Illumination Device in which Said Organoelectroluminescent Element is Used | UDC IRELAND LIMITED (IE) | 2014-08-14 | — | — | US | disclosed |
| US-20140225085-A1 | Organoelectroluminescent Element, and Light Emission Device, Display Device, and Illumination Device in which Said Organoelectroluminescent Element is Used | UDC IRELAND LIMITED (IE) | 2014-08-14 | — | — | US | disclosed |
| US-20080105865-A1 | Pyrene Based Compound and Light Emitting Transistor Element Using the Same | PIONEER CORPORATION (JP) | 2008-05-08 | — | — | US | disclosed |
| EP-1816114-A1 | PYRENE COMPOUND AND LIGHT EMITTING TRANSISTOR DEVICE UTILIZING THE SAME | Rohm Co., Ltd. (JP) | 2007-08-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080105865-A1 | Pyrene Based Compound and Light Emitting Transistor Element Using the Same | CYP1A1, SULT1A1, SULT1E1 | MAOB 2614/4885MAOA 2819/4885KMT2A 2208/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.